How to improve response to rituximab treatment in children with steroid-dependent nephrotic syndrome: answer to Drs. Fujinaga and Nishino
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Hogan J, Dossier C, Kwon T, Macher M-A, Maisin A, Couderc A, Niel O, Baudouin V, Deschênes G (2018) Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol. https://doi.org/10.1007/s00467-018-4052-x
- 3.Jamin A, Berthelot L, Couderc A, Chemouny JM, Boedec E, Dehoux L, Abbad L, Dossier C, Daugas E, Monteiro RC, Deschênes G (2018) Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice. J Autoimmun 89:149–161CrossRefGoogle Scholar
© IPNA 2018